[Edaily Reporter Kang Min-koo ] AHNLAB,INC.(053800)announced preliminary financial results on the 29th, reporting consolidated revenue of 130.4 billion won and operating profit of 7.3 billion won for the first half of this year.
(Source: AHNLAB,INC.) Revenue increased by 10.9 billion won (9.1%) year-over-year, while operating profit rose by 2.8 billion won (62.3%).
In the second quarter of this year, consolidated revenue was 71.3 billion won, and operating profit was 5.4 billion won. Compared to the same period last year, revenue rose by 9.0 billion won (14.5%), and operating profit increased by 1.9 billion won (55.6%).
AHNLAB,INC. official stated, “Revenue from our global business, centered on our Saudi Arabian joint venture ‘Rakin,’ grew by more than double digits compared to the same period last year,” adding, “Amid growing adoption of N²SF and Zero Trust-related products such as AHNLAB EDR and XTG, we recorded triple-digit revenue growth year-over-year.”
The spokesperson added, “We will continue to strengthen the competitiveness of our AI-based products and services,” and noted, “We will also expand our global business to maintain this robust growth momentum.”
Consolidated financial results for the first half of the year. (Unit: million won) (Source: AHNLAB,INC.)
Attention is focused on the reasons behind SK hynix(000660)’s sudden suspension of corporate bond investments. Although the company emerged as a “big player” by aggressively purchasing bonds—starting …
Shin Dong-bin, Chairman of Lotte Group, received the highest compensation among the heads of major retail companies in the first half of this year.
Shin Dong-bin, Chairman of Lotte Group. (Photo co…
JWPHARMACEUTICAL CI (Photo courtesy of JWPHARMACEUTICAL)
JWPHARMACEUTICAL(001060)announced on the 14th that it has submitted an Investigational New Drug (IND) application to the Ministry of Food a…
